Global Markets Direct’s, ‘Traumatic Brain Injury – Pipeline Review, H1 2015’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Traumatic Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traumatic Brain Injury and special features on late-stage and discontinued projects.
For Full Report, Visit here:
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
• The report provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Traumatic Brain Injury and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Traumatic Brain Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Traumatic Brain Injury pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products
Latest Report by Radiant Insights:
Canada Ultrasound Systems Market Outlook to 2020
GlobalData’s new report, “Canada Ultrasound Systems Market Outlook to 2020”, provides key market data on the Canada Ultrasound Systems market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories – B/W Ultrasound Systems (Portable Systems (B/W) and Stand Alone Systems (B/W)) and Color Ultrasound Systems (Portable Systems and Stand Alone Systems).
Frontier Pharma:Liver Cancer-Identifying and Commercializing First-in-Class Innovation
The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market.
To browse more sample reports of this category, visit Radiant Insights
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: Send Email
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States